DekaBank Deutsche Girozentrale’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-17,143	Closed	-$3.36M	–	1302
2019 Q1	$3.36M	Buy	+17,143	New	+$3.31M	0.02%	500
2018 Q4	–	Sell	-17,143	Closed	-$3.36M	–	1268
2018 Q3	$3.36M	Buy	17,143 +7,143	+71%	+$1.69M	0.02%	510
2018 Q2	$2.24M	Buy	+10,000	New	+$2.68M	0.01%	561

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DekaBank Deutsche Girozentrale's DMK Position: Q2 2019 in Review

DekaBank Deutsche Girozentrale sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2019, closing a stake of 17,143 shares — an estimated $3.36M sold.

DekaBank Deutsche Girozentrale first reported a position in DMK in Q2 2018 and held it in 3 quarters. The position peaked at $3.36M in Q1 2019. 51 funds tracked by Wall St. Rank hold DMK as of Q2 2019.

DekaBank Deutsche Girozentrale reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2019 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 17,143 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2019, an estimated $3.36M.
DekaBank Deutsche Girozentrale first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2018 and held it in 3 quarters.
DekaBank Deutsche Girozentrale's DMK Pharmaceuticals Corporation Common Stock position peaked at $3.36M in Q1 2019.
51 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2019.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2019, filed 1 Aug 2019.